Results 21 to 30 of about 200,328 (301)

Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines

open access: yesJournal of Market Access & Health Policy, 2017
Introduction: Health technology assessment (HTA) in Poland supports reimbursement decisions via the Polish HTA Agency (AOTMiT), whose guidelines were updated in 2016.
Krzysztof Lach   +3 more
doaj   +1 more source

Assessing, Pricing and Funding Point-of-Care Diagnostic Tests for Community-Acquired Acute Respiratory Tract Infections–Overview of Policies Applied in 17 European Countries

open access: yesAntibiotics, 2022
Point-of-care diagnostic tests for community-acquired acute respiratory tract infections (CA-ARTI) can support doctors by improving antibiotic prescribing.
Sabine Vogler, Friederike Windisch
doaj   +1 more source

Cost-effectiveness of the use of the continuous subcutaneous insulin infusion pump versus daily multiple injections in type 1 diabetes adult patients at the Mexican Institute of Social Security

open access: yesCost Effectiveness and Resource Allocation, 2019
Background To estimate the incremental cost-effectiveness ratio (ICER) of the use of continuous subcutaneous insulin infusion (CSII) therapy versus multiple daily injections (MDI) therapy in adult patients with type 1 diabetes (T1D) at the Mexican ...
Svetlana V. Doubova   +10 more
doaj   +1 more source

Primary Care Reimbursement Service Statistical Analysis of Claims and Payments 2021 [PDF]

open access: yes, 2022
The Primary Care Reimbursement Service (PCRS) is responsible for reimbursing GPs, Dentists, Pharmacists, Optometrists/Ophthalmologists and other contractors who provide free or reduced-cost services to the public across a range of primary care schemes ...
Primary Care Reimbursement Service (PCRS)
core  

Commercial Payors More Likely to Reimburse Unlisted Hip Arthroscopy Procedures Compared With Managed Care but With Similar Overall Dollar Amount. [PDF]

open access: yesArthrosc Sports Med Rehabil
Purpose To compare the reimbursement practices of public managed care (MC) insurance versus private commercial insurance (COM) for hip arthroscopy using the current procedural terminology (CPT) code 29999. Methods The CPT codes and corresponding reimbursements of hip arthroscopies that employed code 29999 performed from January 2020 to December 2024 in
Neufeld EV   +4 more
europepmc   +2 more sources

Comparison of Cardiovascular Medicines Prices in Four European Countries

open access: yesFrontiers in Public Health, 2020
The aim of the current study was to compare pricing methodologies at the manufacturer, wholesale, and retail levels, and to estimate the price differences of AT1-receptor blockers (sartans), Angiotensin-converting enzyme (ACE)—inhibitors, and their fixed-
Zornitsa Mitkova   +8 more
doaj   +1 more source

Waiting for reimbursement [PDF]

open access: yesScience, 2019
It has been an exciting and productive conference. As a fifth-year Ph.D. student, I am less nervous when I present my work than I used to be, and I finally feel I fit in as a scholar. But when my abstract was accepted in the fall, I had to consider something completely unrelated to my science: whether I could afford to go.
openaire   +2 more sources

Primary Care Reimbursement Service Statistical Analysis of Claims and Payments 2022 [PDF]

open access: yes, 2023
The Primary Care Reimbursement Service (PCRS) is responsible for reimbursing GPs, Dentists, Pharmacists, Optometrists/Ophthalmologists and other contractors who provide free or reduced-cost services to the public across a range of primary care schemes ...
Primary Care Reimbursement Service (PCRS)
core  

A comparative study of orphan drug prices in Europe

open access: yesJournal of Market Access & Health Policy, 2017
Background and Objective: This study assessed price differences by comparing annual treatment costs of similarly available orphan drugs in France, Germany, Italy, Norway, Spain, Sweden, and UK.
Katherine Eve Young   +3 more
doaj   +1 more source

An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries

open access: yesFrontiers in Public Health, 2018
BackgroundPolicy makers face a lot of challenges in the process of drug reimbursement decision-making, especially in the context of entering the market of more and more innovative medicinal products (MPs).
Maria Kamusheva   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy